Canada markets closed

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.31700.0000 (0.00%)
At close: 03:15PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.17M
Enterprise Value -63.58k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.05
Price/Book (mrq)1.78
Enterprise Value/Revenue 0.01
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 3-88.39%
S&P500 52-Week Change 326.24%
52 Week High 33.4000
52 Week Low 30.2000
50-Day Moving Average 30.3796
200-Day Moving Average 31.2724

Share Statistics

Avg Vol (3 month) 3126.32k
Avg Vol (10 day) 319.27k
Shares Outstanding 56.86M
Implied Shares Outstanding 66.86M
Float 86.85M
% Held by Insiders 10.22%
% Held by Institutions 10.03%
Shares Short (Feb 29, 2024) 4222.1k
Short Ratio (Feb 29, 2024) 40.28
Short % of Float (Feb 29, 2024) 47.50%
Short % of Shares Outstanding (Feb 29, 2024) 47.49%
Shares Short (prior month Jan 31, 2024) 4189.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Apr 11, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin -36.24%
Operating Margin (ttm)-48.23%

Management Effectiveness

Return on Assets (ttm)-75.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)21.5M
Revenue Per Share (ttm)6.96
Quarterly Revenue Growth (yoy)49.90%
Gross Profit (ttm)N/A
EBITDA -15.54M
Net Income Avi to Common (ttm)-7.79M
Diluted EPS (ttm)-0.5200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.62M
Total Cash Per Share (mrq)0.38
Total Debt (mrq)378k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.56
Book Value Per Share (mrq)-1.51

Cash Flow Statement

Operating Cash Flow (ttm)-10.46M
Levered Free Cash Flow (ttm)-6.11M